Peter E. Daddona - Concepedia

Author

Peter E. Daddona

Also Known As

Daddona, Peter E., P DADDONA, P Daddona, P E DADDONA, P E Daddona, P. Daddona, P. E. DADDONA, P. E. Daddona, P.E. Daddona, PETER E. DADDONA

114

Publications

Citations

H-Index

146

Concepts

All Affiliations

University of Michigan University of Manitoba Reaction Biology Corporation (United States)

About

Peter E. Daddona is an author at University of Michigan specializing in medicine, immunology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	53	4K
2	Natural Sciences	14	14	583
3	Engineering	7	7	448
4	Health Sciences	7	7	291
5	Social Sciences	7	7	273

Peter E. Daddona

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
Construction and initial characterization of a mouse-human chimeric anti-TNF antibody David Knight, Han Trinh, Junming Le, Molecular Immunology Autoimmune DiseaseAllergyImmunologyImmunodominanceAntibody Screening	1993	710
Macroflux® Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization James A. Matriano, Michel Cormier, Juanita Johnson, Pharmaceutical Research	2002	365
Transdermal delivery of desmopressin using a coated microneedle array patch system Michel Cormier, B JOHNSON, Masih Ameri, Journal of Controlled Release Transdermal DeliveryTopical DrugWound HealingBiomedical EngineeringDermatology	2004	283
Parathyroid Hormone (1-34)-Coated Microneedle Patch System: Clinical Pharmacokinetics and Pharmacodynamics for Treatment of Osteoporosis Peter E. Daddona, James A. Matriano, Jaap W. Mandema, Pharmaceutical Research Bone DiseaseOrthopaedic SurgeryParathyroid HormoneParathyroid DiseaseParathyroid Gland	2010	229
The Mouse/Human Chimeric Monoclonal Antibody cA2 Neutralizes TNF In Vitro and Protects Transgenic Mice from Cachexia and TNF Lethality In Vivo Scott A. Siegel, David J. Shealy, Marian T. Nakada, Cytokine Tnf LethalityHuman TnfImmunologyCell DeathPathology	1995	227
Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells. Barry Mitchell, Erick Perez Mejias, Peter E. Daddona, Proceedings of the National Academy of Sciences Clinical ImmunologyImmunotoxicologyLymphocyte DevelopmentImmunodeficienciesImmunology	1978	209
Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system Georg Widera, John B. Johnson, Lee-Hyung Kim, Vaccine VaccinationMucosal VaccinationAllergyVaccine DevelopmentIntracutaneous Administration	2005	205
Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity. Zenon Steplewski, Lee K. Sun, Clyde W. Shearman, Proceedings of the National Academy of Sciences ImmunologyImmunoeditingPathologyImmunotherapyTumor Immunity	1988	204
Transdermal Delivery of Antisense Oligonucleotides with Microprojection Patch (macroflux®) Technology WeiQi Lin, Michel Cormier, Ahmad Samiee, Pharmaceutical Research	2001	188
Human adenosine deaminase. Purification and subunit structure. Peter E. Daddona, William N. Kelley Journal of Biological Chemistry Human Adenosine DeaminaseEngineeringCellular EnzymologyBiochemistryPurified Adenosine Deaminase	1977	154

Page 1